CRISPR biotechs band together in IP pact – BioPharma Dive
MedCity News |
CRISPR biotechs band together in IP pact
BioPharma Dive Amid a high-profile legal battle, a group of CRISPR biotechs have banded together to coordinate the defense and enforcement of key patents tied to the promising, yet still unproven, gene-editing technology. CRISPR Therapeutics, Intellia Therapeutics, … CRISPR Companies Ink IP Collaboration with Charpentier-UC Patent Holders CRISPR Therapeutics, Intellia Therapeutics, Caribou Biosciences and ERS Genomics Announce Global Agreement on … Some consensus in the CRISPR patent case |
